Novo Nordisk AS (NONOF)
105.00
+2.16
(+2.10%)
USD |
OTCM |
Nov 22, 16:00
Novo Nordisk Gross Profit Margin (Quarterly): 84.14% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 84.14% |
| June 30, 2024 | 84.90% |
| March 31, 2024 | 84.83% |
| December 31, 2023 | 84.80% |
| September 30, 2023 | 83.46% |
| June 30, 2023 | 85.53% |
| March 31, 2023 | 84.67% |
| December 31, 2022 | 82.82% |
| September 30, 2022 | 84.20% |
| June 30, 2022 | 85.29% |
| March 31, 2022 | 83.54% |
| December 31, 2021 | 83.72% |
| September 30, 2021 | 82.99% |
| June 30, 2021 | 83.21% |
| March 31, 2021 | 82.81% |
| December 31, 2020 | 82.52% |
| September 30, 2020 | 83.33% |
| June 30, 2020 | 84.10% |
| March 31, 2020 | 84.10% |
| December 31, 2019 | 83.24% |
| September 30, 2019 | 83.24% |
| June 30, 2019 | 83.86% |
| March 31, 2019 | 83.84% |
| December 31, 2018 | 84.35% |
| September 30, 2018 | 84.10% |
| Date | Value |
|---|---|
| June 30, 2018 | 84.12% |
| March 31, 2018 | 84.42% |
| December 31, 2017 | 83.21% |
| September 30, 2017 | 83.95% |
| June 30, 2017 | 84.60% |
| March 31, 2017 | 85.06% |
| December 31, 2016 | 83.37% |
| September 30, 2016 | 85.52% |
| June 30, 2016 | 85.27% |
| March 31, 2016 | 84.44% |
| December 31, 2015 | 84.04% |
| September 30, 2015 | 85.64% |
| June 30, 2015 | 85.74% |
| March 31, 2015 | 84.63% |
| December 31, 2014 | 83.73% |
| September 30, 2014 | 84.60% |
| June 30, 2014 | 83.03% |
| March 31, 2014 | 82.96% |
| December 31, 2013 | 84.33% |
| September 30, 2013 | 82.81% |
| June 30, 2013 | 83.13% |
| March 31, 2013 | 81.94% |
| December 31, 2012 | 84.96% |
| September 30, 2012 | 82.44% |
| June 30, 2012 | 82.41% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
82.52%
Minimum
Dec 2020
85.53%
Maximum
Jun 2023
83.91%
Average
83.91%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 81.02% |
| Genmab AS | 95.07% |
| Ascendis Pharma AS | 80.63% |
| Galecto Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 88.95% |
| Return on Assets | 28.14% |
| Return on Invested Capital | 65.63% |
| Profit Margin (Quarterly) | 38.28% |
| Operating Margin (Quarterly) | 47.43% |
| Return on Net Operating Assets | 31.93% |